Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis.

Timmermann L, Rosumeck N, Klein F, Pratschke J, Pelzer U, Bahra M, Malinka T.

Anticancer Res. 2019 Oct;39(10):5781-5787. doi: 10.21873/anticanres.13781.

PMID:
31570482
2.

Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.

Petry-Schmelzer JN, Krause M, Dembek TA, Horn A, Evans J, Ashkan K, Rizos A, Silverdale M, Schumacher W, Sack C, Loehrer PA, Fink GR, Fonoff ET, Martinez-Martin P, Antonini A, Barbe MT, Visser-Vandewalle V, Ray-Chaudhuri K, Timmermann L, Dafsari HS.

Brain. 2019 Sep 23. pii: awz285. doi: 10.1093/brain/awz285. [Epub ahead of print]

PMID:
31553039
3.

Postoperative acute necrotizing pancreatitis of the pancreatic remnant (POANP): a new definition of severe pancreatitis following pancreaticoduodenectomy.

Globke B, Timmermann L, Klein F, Fehrenbach U, Pratschke J, Bahra M, Malinka T.

HPB (Oxford). 2019 Aug 17. pii: S1365-182X(19)30635-5. doi: 10.1016/j.hpb.2019.07.016. [Epub ahead of print]

PMID:
31431414
4.

[Update on diagnostics and therapy of idiopathic Parkinson's disease].

Waldthaler J, Timmermann L.

Fortschr Neurol Psychiatr. 2019 Aug;87(8):445-461. doi: 10.1055/a-0952-8075. Epub 2019 Aug 20. Review. German.

PMID:
31430812
5.

Probabilistic sweet spots predict motor outcome for deep brain stimulation in Parkinson disease.

Dembek TA, Roediger J, Horn A, Reker P, Oehrn C, Dafsari HS, Li N, Kühn AA, Fink GR, Visser-Vandewalle V, Barbe MT, Timmermann L.

Ann Neurol. 2019 Oct;86(4):527-538. doi: 10.1002/ana.25567.

PMID:
31376171
6.

Evaluation of Spike Sorting Algorithms: Application to Human Subthalamic Nucleus Recordings and Simulations.

Sukiban J, Voges N, Dembek TA, Pauli R, Visser-Vandewalle V, Denker M, Weber I, Timmermann L, Grün S.

Neuroscience. 2019 Aug 21;414:168-185. doi: 10.1016/j.neuroscience.2019.07.005. Epub 2019 Jul 9.

7.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
8.

Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability.

Pelzer EA, Melzer C, Schönberger A, Hess M, Timmermann L, Eggers C, Tittgemeyer M.

Neuroimage Clin. 2019;23:101906. doi: 10.1016/j.nicl.2019.101906. Epub 2019 Jun 21.

9.

Author response: DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial.

Barbe MT, Reker P, Hamacher S, Franklin J, Kraus D, Dembek TA, Becker J, Steffen JK, Allert N, Wirths J, Dafsari HS, Voges J, Fink GR, Visser-Vandewalle V, Timmermann L.

Neurology. 2019 May 14;92(20):975-976. doi: 10.1212/WNL.0000000000007521. No abstract available.

PMID:
31085731
10.

Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model.

Apetz N, Kordys E, Simon M, Mang B, Aswendt M, Wiedermann D, Neumaier B, Drzezga A, Timmermann L, Endepols H.

Dis Model Mech. 2019 May 24;12(5). pii: dmm039065. doi: 10.1242/dmm.039065.

11.

Adverse events associated with deep brain stimulation in patients with childhood-onset dystonia.

Koy A, Bockhorn N, Kühn AA, Schneider GH, Krause P, Lauritsch K, Witt K, Paschen S, Deuschl G, Krauss JK, Saryyeva A, Runge J, Borggraefe I, Mehrkens JH, Horn A, Vesper J, Schnitzler A, Siegert S, Freilinger M, Eckenweiler M, Coenen VA, Tadic V, Voges J, Pauls KAM, Wirths J, Timmermann L, Hellmich M; GEPESTIM consortium.

Brain Stimul. 2019 Sep - Oct;12(5):1111-1120. doi: 10.1016/j.brs.2019.04.003. Epub 2019 Apr 13.

PMID:
31031208
12.

Cis-4-[18F]fluoro-D-proline detects neurodegeneration in patients with akinetic-rigid parkinsonism.

Sommerauer M, Galldiks N, Barbe MT, Stoffels G, Willuweit A, Coenen HH, Schroeter M, Timmermann L, Fink GR, Langen KJ.

Nucl Med Commun. 2019 Apr;40(4):383-387. doi: 10.1097/MNM.0000000000000982.

PMID:
30875335
13.

Decoding voluntary movements and postural tremor based on thalamic LFPs as a basis for closed-loop stimulation for essential tremor.

Tan H, Debarros J, He S, Pogosyan A, Aziz TZ, Huang Y, Wang S, Timmermann L, Visser-Vandewalle V, Pedrosa DJ, Green AL, Brown P.

Brain Stimul. 2019 Jul - Aug;12(4):858-867. doi: 10.1016/j.brs.2019.02.011. Epub 2019 Feb 21.

14.

Connectivity Profile Predictive of Effective Deep Brain Stimulation in Obsessive-Compulsive Disorder.

Baldermann JC, Melzer C, Zapf A, Kohl S, Timmermann L, Tittgemeyer M, Huys D, Visser-Vandewalle V, Kühn AA, Horn A, Kuhn J.

Biol Psychiatry. 2019 May 1;85(9):735-743. doi: 10.1016/j.biopsych.2018.12.019. Epub 2019 Jan 9.

PMID:
30777287
15.

Open-label trial of anterior limb of internal capsule-nucleus accumbens deep brain stimulation for obsessive-compulsive disorder: insights gained.

Huys D, Kohl S, Baldermann JC, Timmermann L, Sturm V, Visser-Vandewalle V, Kuhn J.

J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):805-812. doi: 10.1136/jnnp-2018-318996. Epub 2019 Feb 15.

PMID:
30770458
16.

Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control.

Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, Timmermann L, Fink GR, Drzezga A, Eggers C, van Eimeren T.

Brain. 2019 Mar 1;142(3):733-743. doi: 10.1093/brain/awz007.

PMID:
30753324
17.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

18.

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.

Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.

PMID:
30719763
19.

Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease.

Glaab E, Trezzi JP, Greuel A, Jäger C, Hodak Z, Drzezga A, Timmermann L, Tittgemeyer M, Diederich NJ, Eggers C.

Neurobiol Dis. 2019 Apr;124:555-562. doi: 10.1016/j.nbd.2019.01.003. Epub 2019 Jan 9.

20.

Implementation of Intraoperative Computed Tomography for Deep Brain Stimulation: Pitfalls and Optimization of Workflow, Accuracy, and Radiation Exposure.

Carl B, Bopp M, Gjorgjevski M, Oehrn C, Timmermann L, Nimsky C.

World Neurosurg. 2018 Dec 27. pii: S1878-8750(18)32902-4. doi: 10.1016/j.wneu.2018.12.079. [Epub ahead of print]

PMID:
30593970
21.

Inpatient treatment of trekkers and Nepalese workers in the high-altitude environment of Mt. Everest Region 1996-2011: A retrospective analysis.

Kühn C, Apel C, Bertsch D, Grass M, Gschwandtl C, Hundt N, Müller-Ost M, Risse J, Schmitz S, Sherpa K, Timmermann L, van der Giet M, van der Giet S, Wernitz K, Morrison A, Küpper T.

Travel Med Infect Dis. 2018 Nov 28:101356. doi: 10.1016/j.tmaid.2018.11.012. [Epub ahead of print]

PMID:
30502547
22.

Reply to "The paper that wrote itself-a ghost story".

Schüpbach M, Chabardes S, Matthies C, Pollo C, Steigerwald F, Timmermann L, Visser Vandewalle V, Volkmann J, Schuurman PR.

Mov Disord. 2018 Sep;33(9):1510-1511. doi: 10.1002/mds.27464. Epub 2018 Sep 7. No abstract available.

PMID:
30192032
23.

Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease.

Barbe MT, Barthel C, Chen L, Van Dyck N, Brücke T, Seijo F, San Martin ES, Haegelen C, Verin M, Amarell M, Gill S, Whone A, Porta M, Servello D, Fink GR, Alesch F, Bloem BR, Timmermann L.

Brain Stimul. 2018 Nov - Dec;11(6):1404-1406. doi: 10.1016/j.brs.2018.08.016. Epub 2018 Aug 27. No abstract available.

24.

Health-Related Quality of Life Subdomains in Patients with Parkinson's Disease: The Role of Gender.

Ophey A, Eggers C, Dano R, Timmermann L, Kalbe E.

Parkinsons Dis. 2018 Aug 1;2018:6532320. doi: 10.1155/2018/6532320. eCollection 2018.

25.

Unstable impedance of a single electrode contact resulting in loss of DBS therapy-a case report.

Allert N, Lindlau A, Quindt R, Reker P, Timmermann L, Barbe MT.

Acta Neurochir (Wien). 2018 Dec;160(12):2485-2488. doi: 10.1007/s00701-018-3658-x. Epub 2018 Aug 17.

PMID:
30120541
26.

Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.

Dafsari HS, Ray-Chaudhuri K, Mahlstedt P, Sachse L, Steffen JK, Petry-Schmelzer JN, Dembek TA, Reker P, Barbe MT, Visser-Vandewalle V, Fink GR, Timmermann L.

Eur J Neurol. 2019 Feb;26(2):222-e17. doi: 10.1111/ene.13773. Epub 2018 Sep 21.

PMID:
30107062
27.

Access to End-of Life Parkinson's Disease Patients Through Patient-Centered Integrated Healthcare.

Eggers C, Dano R, Schill J, Fink GR, Timmermann L, Voltz R, Golla H, Lorenzl S.

Front Neurol. 2018 Jul 30;9:627. doi: 10.3389/fneur.2018.00627. eCollection 2018.

28.

A functional micro-electrode mapping of ventral thalamus in essential tremor.

Pedrosa DJ, Brown P, Cagnan H, Visser-Vandewalle V, Wirths J, Timmermann L, Brittain JS.

Brain. 2018 Sep 1;141(9):2644-2654. doi: 10.1093/brain/awy192.

29.

DBS of the PSA and the VIM in essential tremor: A randomized, double-blind, crossover trial.

Barbe MT, Reker P, Hamacher S, Franklin J, Kraus D, Dembek TA, Becker J, Steffen JK, Allert N, Wirths J, Dafsari HS, Voges J, Fink GR, Visser-Vandewalle V, Timmermann L.

Neurology. 2018 Aug 7;91(6):e543-e550. doi: 10.1212/WNL.0000000000005956. Epub 2018 Jul 3.

PMID:
29970404
30.

A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.

Henrich MT, Geibl FF, Lee B, Chiu WH, Koprich JB, Brotchie JM, Timmermann L, Decher N, Matschke LA, Oertel WH.

Acta Neuropathol Commun. 2018 May 10;6(1):39. doi: 10.1186/s40478-018-0541-1.

31.

Dopamine substitution alters effective connectivity of cortical prefrontal, premotor, and motor regions during complex bimanual finger movements in Parkinson's disease.

Nettersheim FS, Loehrer PA, Weber I, Jung F, Dembek TA, Pelzer EA, Dafsari HS, Huber CA, Tittgemeyer M, Timmermann L.

Neuroimage. 2019 Apr 15;190:118-132. doi: 10.1016/j.neuroimage.2018.04.030. Epub 2018 Apr 23.

PMID:
29698732
32.

Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.

Dafsari HS, Weiß L, Silverdale M, Rizos A, Reddy P, Ashkan K, Evans J, Reker P, Petry-Schmelzer JN, Samuel M, Visser-Vandewalle V, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):867-874. doi: 10.1016/j.brs.2018.02.015. Epub 2018 Feb 24.

PMID:
29655587
33.

Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.

Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, Ashkan K, Weis L, Dembek TA, Samuel M, Rizos A, Silverdale M, Barbe MT, Fink GR, Evans J, Martinez-Martin P, Antonini A, Visser-Vandewalle V, Timmermann L; EUROPAR; IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):904-912. doi: 10.1016/j.brs.2018.03.009. Epub 2018 Mar 16.

PMID:
29655586
34.

Management of constipation in patients with Parkinson's disease.

Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ.

NPJ Parkinsons Dis. 2018 Mar 16;4:6. doi: 10.1038/s41531-018-0042-8. eCollection 2018. Review.

35.

An observational study of rotigotine transdermal patch and other currently prescribed therapies in patients with Parkinson's disease.

Müller T, Tolosa E, Badea L, Asgharnejad M, Grieger F, Markowitz M, Nondonfaz X, Bauer L, Timmermann L.

J Neural Transm (Vienna). 2018 Jun;125(6):953-963. doi: 10.1007/s00702-018-1860-x. Epub 2018 Feb 26.

PMID:
29484495
36.

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.

Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2018 Mar;33(3):421-430. doi: 10.1002/mds.27283. Epub 2018 Feb 21.

PMID:
29465787
37.

Randomized, double-blind, crossover study of the adhesiveness of two formulations of rotigotine transdermal patch in patients with Parkinson's disease.

Elshoff JP, Bauer L, Goldammer N, Oortgiesen M, Pesch H, Timmermann L.

Curr Med Res Opin. 2018 Jul;34(7):1293-1299. doi: 10.1080/03007995.2018.1430559. Epub 2018 Feb 20.

PMID:
29461870
38.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
39.

Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial.

Eggers C, Dano R, Schill J, Fink GR, Hellmich M, Timmermann L; CPN study group.

J Neurol. 2018 Apr;265(4):764-773. doi: 10.1007/s00415-018-8761-7. Epub 2018 Feb 1.

PMID:
29392459
40.

The effects of Thalamic Deep Brain Stimulation on speech dynamics in patients with Essential Tremor: An articulographic study.

Mücke D, Hermes A, Roettger TB, Becker J, Niemann H, Dembek TA, Timmermann L, Visser-Vandewalle V, Fink GR, Grice M, Barbe MT.

PLoS One. 2018 Jan 23;13(1):e0191359. doi: 10.1371/journal.pone.0191359. eCollection 2018.

41.

Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson's disease.

Schwartz F, Tahmasian M, Maier F, Rochhausen L, Schnorrenberg KL, Samea F, Seemiller J, Zarei M, Sorg C, Drzezga A, Timmermann L, Meyer TD, van Eimeren T, Eggers C.

Brain Imaging Behav. 2019 Feb;13(1):241-254. doi: 10.1007/s11682-017-9812-x.

PMID:
29322397
42.

Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease.

Dafsari HS, Reker P, Silverdale M, Reddy P, Pilleri M, Martinez-Martin P, Rizos A, Perrier E, Weiß L, Ashkan K, Samuel M, Evans J, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non-Motor PD Study Group.

Neuromodulation. 2018 Aug;21(6):532-540. doi: 10.1111/ner.12740. Epub 2017 Dec 20.

PMID:
29266613
43.

Pulse duration settings in subthalamic stimulation for Parkinson's disease.

Steigerwald F, Timmermann L, Kühn A, Schnitzler A, Reich MM, Kirsch AD, Barbe MT, Visser-Vandewalle V, Hübl J, van Riesen C, Groiss SJ, Moldovan AS, Lin S, Carcieri S, Manola L, Volkmann J.

Mov Disord. 2018 Jan;33(1):165-169. doi: 10.1002/mds.27238. Epub 2017 Nov 22.

44.

Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.

Dafsari HS, Reker P, Stalinski L, Silverdale M, Rizos A, Ashkan K, Barbe MT, Fink GR, Evans J, Steffen J, Samuel M, Dembek TA, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Martinez-Martin P, Timmermann L; EUROPAR and the IPMDS (International Parkinson's and Movement Disorders Society) Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2018 Jan;33(1):99-107. doi: 10.1002/mds.27222. Epub 2017 Nov 18.

PMID:
29150860
45.

The influence of filtering and downsampling on the estimation of transfer entropy.

Weber I, Florin E, von Papen M, Timmermann L.

PLoS One. 2017 Nov 17;12(11):e0188210. doi: 10.1371/journal.pone.0188210. eCollection 2017.

46.

Dysarthria in pallidal Deep Brain Stimulation in dystonia depends on the posterior location of active electrode contacts: a pilot study.

Pauls KAM, Bröckelmann PJ, Hammesfahr S, Becker J, Hellerbach A, Visser-Vandewalle V, Dembek TA, Meister IG, Timmermann L.

Parkinsonism Relat Disord. 2018 Feb;47:71-75. doi: 10.1016/j.parkreldis.2017.11.002. Epub 2017 Nov 7.

47.

Pallidal DBS for dystonia in the age of personalized medicine.

Pauls KAM, Krauss JK, Kühn AA, Moro E, Fink GR, Volkmann J, Timmermann L.

Parkinsonism Relat Disord. 2017 Dec;45:101-102. doi: 10.1016/j.parkreldis.2017.09.007. Epub 2017 Sep 14.

PMID:
28964627
48.

Phase-coherence classification: A new wavelet-based method to separate local field potentials into local (in)coherent and volume-conducted components.

von Papen M, Dafsari HS, Florin E, Gerick F, Timmermann L, Saur J.

J Neurosci Methods. 2017 Nov 1;291:198-212. doi: 10.1016/j.jneumeth.2017.08.021. Epub 2017 Aug 31.

PMID:
28843679
49.

Directional leads for deep brain stimulation: Opportunities and challenges.

Schüpbach WMM, Chabardes S, Matthies C, Pollo C, Steigerwald F, Timmermann L, Visser Vandewalle V, Volkmann J, Schuurman PR.

Mov Disord. 2017 Oct;32(10):1371-1375. doi: 10.1002/mds.27096. Epub 2017 Aug 26. Review. No abstract available.

50.

Directional DBS increases side-effect thresholds-A prospective, double-blind trial.

Dembek TA, Reker P, Visser-Vandewalle V, Wirths J, Treuer H, Klehr M, Roediger J, Dafsari HS, Barbe MT, Timmermann L.

Mov Disord. 2017 Oct;32(10):1380-1388. doi: 10.1002/mds.27093. Epub 2017 Aug 26.

PMID:
28843009

Supplemental Content

Loading ...
Support Center